Literature DB >> 22293142

Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period.

Ruben Coronel1, Michiel J Janse, Tobias Opthof, Arthur A Wilde, Peter Taggart.   

Abstract

Action potential duration is widely used as a measure of refractory period in ischemia. Although the end of repolarization closely corresponds to the end of refractoriness in the well-perfused, well-oxygenated myocardium, it is no longer true for the ischemic myocardium, in which the recovery of excitability lags behind full repolarization. The purpose the study was to review this phenomenon of postrepolarization refractoriness during ischemia and after application of various antiarrhythmic drugs. The findings showed that although postrepolarization refractoriness is profoundly proarrhythmic during ischemia, it may protect the heart from reentrant arrhythmias in the absence of depolarization of the resting membrane. An increase in postrepolarization refractoriness induced by sodium-channel-blocking drugs may exert an antifibrillatory action.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293142     DOI: 10.1016/j.hrthm.2012.01.021

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  17 in total

1.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

2.  Mitochondrial depolarization and electrophysiological changes during ischemia in the rabbit and human heart.

Authors:  Matthew S Sulkin; Bas J Boukens; Megan Tetlow; Sarah R Gutbrod; Fu Siong Ng; Igor R Efimov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

3.  Functional roles of KATP channel subunits in metabolic inhibition.

Authors:  Alexey V Glukhov; Keita Uchida; Igor R Efimov; Colin G Nichols
Journal:  J Mol Cell Cardiol       Date:  2013-04-23       Impact factor: 5.000

Review 4.  Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia.

Authors:  Joshua A Keefe; Oliver M Moore; Kevin S Ho; Xander H T Wehrens
Journal:  Arch Toxicol       Date:  2022-10-10       Impact factor: 6.168

5.  Adverse remodeling of the electrophysiological response to ischemia-reperfusion in human heart failure is associated with remodeling of metabolic gene expression.

Authors:  Fu Siong Ng; Katherine M Holzem; Aaron C Koppel; Deborah Janks; Fabiana Gordon; Andrew L Wit; Nicholas S Peters; Igor R Efimov
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-11

6.  Control of ventricular excitability by neurons of the dorsal motor nucleus of the vagus nerve.

Authors:  Asif Machhada; Richard Ang; Gareth L Ackland; Natalia Ninkina; Vladimir L Buchman; Mark F Lythgoe; Stefan Trapp; Andrew Tinker; Nephtali Marina; Alexander V Gourine
Journal:  Heart Rhythm       Date:  2015-06-05       Impact factor: 6.343

7.  Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block.

Authors:  Jakub Tomek; Alfonso Bueno-Orovio; Elisa Passini; Xin Zhou; Ana Minchole; Oliver Britton; Chiara Bartolucci; Stefano Severi; Alvin Shrier; Laszlo Virag; Andras Varro; Blanca Rodriguez
Journal:  Elife       Date:  2019-12-24       Impact factor: 8.140

Review 8.  Combining wet and dry research: experience with model development for cardiac mechano-electric structure-function studies.

Authors:  T Alexander Quinn; Peter Kohl
Journal:  Cardiovasc Res       Date:  2013-01-17       Impact factor: 10.787

9.  Human-based approaches to pharmacology and cardiology: an interdisciplinary and intersectorial workshop.

Authors:  Blanca Rodriguez; Annamaria Carusi; Najah Abi-Gerges; Rina Ariga; Oliver Britton; Gil Bub; Alfonso Bueno-Orovio; Rebecca A B Burton; Valentina Carapella; Louie Cardone-Noott; Matthew J Daniels; Mark R Davies; Sara Dutta; Andre Ghetti; Vicente Grau; Stephen Harmer; Ivan Kopljar; Pier Lambiase; Hua Rong Lu; Aurore Lyon; Ana Minchole; Anna Muszkiewicz; Julien Oster; Michelangelo Paci; Elisa Passini; Stefano Severi; Peter Taggart; Andy Tinker; Jean-Pierre Valentin; Andras Varro; Mikael Wallman; Xin Zhou
Journal:  Europace       Date:  2015-11-29       Impact factor: 5.214

10.  β-Adrenergic Inhibition Prevents Action Potential and Calcium Handling Changes during Regional Myocardial Ischemia.

Authors:  Shannon R Murphy; Lianguo Wang; Zhen Wang; Philip Domondon; Di Lang; Beth A Habecker; Rachel C Myles; Crystal M Ripplinger
Journal:  Front Physiol       Date:  2017-08-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.